Clinical Trial Update: Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a one-dose versus two-dose graded direct oral challenge to delabel penicillin allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penicillin Allergy

Drugs mentioned

• Penicillin (penicillin)

Snippet

Sponsor: James Tarbox, MD | Conditions: Penicillin Allergy | Phase 3 | Status: RECRUITING